ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →

Thursday, 12 November 2026 Every NSE & BSE announcement, by company

ALFA Filings Every announcement, straight from the exchange

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK · BSE: 532296 · Pharmaceuticals & Biotechnology · 47 announcements

Glenmark Pharmaceuticals Ltd news stories on ALFA NewsRead the news →

Share price: ₹2,677.20
Market cap: ₹75,557 Cr
Revenue (annual): ₹16,983 Cr
Net profit (annual): ₹1,362 Cr
P/E (TTM): 52.1×Sector 43.8×
Promoter holding: 46.65%+0.00% QoQ
FII holding: 21.51%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Product Launch 3 Other Announcement 3 Earnings Call 2 Business Update 2 Annual General Meeting 2 Results Update 1 Financial Results 1 Credit Rating 1 Board Meeting Date 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

5 Nov 2026 17:04 IST NSE

Financial Results

Glenmark Pharmaceuticals Q2 FY27 Results: Net Profit ₹263.8 Cr, Down 56.8% YoY

Glenmark Pharmaceuticals Ltd reported revenue from operations of ₹4,247 Cr (-29.8% YoY) and net profit of ₹263.8 Cr (-56.8% YoY) for Q2 FY27.

Key figure: Net profit ₹263.8 Cr · -56.8% YoY

Open full results → Read the filing ↗

Glenmark Pharmaceuticals Ltd by type